Cavin‐2 promotes fibroblast‐to‐myofibroblast trans‐differentiation and aggravates cardiac fibrosis
Abstract Aims Transforming growth factor β (TGF‐β) signalling is one of the critical pathways in fibroblast activation, and several drugs targeting the TGF‐β/Smad signalling pathway in heart failure with cardiac fibrosis are being tested in clinical trials. Some caveolins and cavins, which are compo...
Main Authors: | Yusuke Higuchi, Takehiro Ogata, Naohiko Nakanishi, Masahiro Nishi, Yumika Tsuji, Shinya Tomita, Simon J. Conway, Satoaki Matoba |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-02-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.14571 |
Similar Items
-
Requirement of Cavin-2 for the expression and stability of IRβ in adequate adipocyte differentiation
by: Yusuke Higuchi, et al.
Published: (2022-01-01) -
Prognostic and Diagnostic Significance of SDPR-Cavin-2 in Hepatocellular Carcinoma
by: Wei Jing, et al.
Published: (2016-08-01) -
UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1
by: Xiaotong Cen, et al.
Published: (2022-11-01) -
The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding
by: Shinya Tomita, et al.
Published: (2024-01-01) -
Systems Network Genomic Analysis Reveals Cardioprotective Effect of MURC/Cavin‐4 Deletion Against Ischemia/Reperfusion Injury
by: Masahiro Nishi, et al.
Published: (2019-08-01)